Social: #SCHD22
Twitter: @btfoundation
Facebook: @binaytarafoundation
LinkedIn: Binaytara Foundation
Website: https://education.binayfoundation.org/oncology_conference_SCHD22
OUR CONFERENCE WILL PROVIDE RAPID ANTIGEN COVID19 TESTING FOR ALL ATTENDEES AND FACULTY.
This annual oncology conference, 2022 Summit on Cancer Health Disparities (SCHD22), will feature lectures, panel discussions and debates among leaders across the spectrum of cancer care delivery. This conference will bring together oncology professionals, cancer disparity researchers, and other stakeholders to discuss the factors leading to cancer health disparities and ways to overcome the impact of these factors to optimize outcomes of cancer patients.
SCHD22 is an accredited continuing education activity (CME activity) that will foster collaborative interdisciplinary interactions and partnerships to stimulate the development of new research and clinical practices that reduce cancer health disparities and improve outcomes of the diverse patient population.
TARGET AUDIENCE
Oncologist and Hematologists
Oncology and Hematology Nurse Practitioners
Oncology and Hematology Physician Assistants
Oncology and Hematology Nurses
Oncology and Hematology Pharmacists
Oncology and Hematology Fellows/Residents
Oncology and Hematology Researchers
Others interested in cancer disparities
LEARNING OBJECTIVES
Identify drivers of cancer health disparities and review their impact on patients along the cancer continuum.
State the financial and physical barriers, review strategies to navigate these factors to optimize management of patients with cancer.
Incorporate evidence-based strategies to minimize the impact of specific drivers of inequity in the management of patients with cancer.
Describe challenges and develop novel approaches to improve participation of underrepresented communities in clinical trials.